CVS Cuts 2024 Earnings Guidance Amid Rising Medical Costs and Medicare Advantage Challenges
The Challenges Ahead for CVS Pharmacy New Earnings Guidance and Impact on Industry A person walks by a CVS Pharmacy store in Manhattan, New York, on Nov. 15, 2021. CVS Pharmacy, a leading drugstore chain, has revised its adjusted earnings guidance for 2024, lowering it to at least $7 per share compared to the previous … Read more